在炎症性肠病中产生梅萨拉诱导的心肌炎:系统性审查
Kiran Jhakri1, Moath Al-Shudifat2, Bushra Sumra3
1Internal Medicine, Shahjalal University of Science and Technology, Sylhet, BGD.
Cureus
|March 3, 2025
概括
炎症性肠病 (IBD) 中心肌炎通常是对梅萨拉的严重药物反应,而不是IBD并发症. 治疗包括停止使用药物并使用免疫抑制剂.
科学领域:
- 胃肠病学 胃肠病学
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 炎症性肠病 (IBD),包括克罗恩病 (CD) 和性结肠炎 (UC),是一种慢性免疫介导的胃肠道疾病.
- 心肌炎,心肌的炎症,是IBD的罕见但严重的并发症,影响大约0.3%的患者.
- 梅萨拉是一种标准的IBD治疗方法,但梅萨拉诱导的心肌炎是一种罕见的药物不良反应,可能致命.
研究的目的:
- 在IBD患者中描述梅萨拉诱导心肌炎的临床特征.
- 分析与梅萨拉相关的心肌炎病例,并审查IBD中心肌炎的文献.
- 阐明病理生理机制,区分药物反应和肠外表现.
主要方法:
- 按照PRISMA 2020指南进行系统审查.
- 在Cochrane,ScienceDirect,Google Scholar,PubMed和PMC (2014-2024) 中进行文献搜索.
- 严格的质量评估包括的研究.
主要成果:
- 对43名患者的分析显示,67%的人患有可归因于梅萨拉的心肌炎.
- 梅萨拉衍生物 (硫萨拉,梅萨拉,巴尔萨拉齐德) 经常与药物诱导的心肌炎有关.
- 在IBD中心肌炎更可能是严重的药物反应而不是肠外表现.
结论:
- 梅萨拉诱导的心肌炎是IBD管理中的一个重大问题.
- 潜在的机制包括过敏反应,直接心脏毒性或对药物代谢物的反应.
- 有效的治疗包括药物停用和免疫抑制疗法.
相关概念视频
01:29Drugs for Treatment of Ulcerative Colitis in IBD
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide generation.
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
01:29Inflammatory Bowel Disease IV: Pharmacological Management
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
01:26Inflammatory Bowel Disease I: Introduction
Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows “skip lesions” in which...
01:20Inflammatory Bowel Disease II: Ulcerative Colitis
Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
01:25Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...